Investigation of the Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen
Phase of Trial: Phase I
Latest Information Update: 28 Jan 2009
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Grass pollen hypersensitivity; Seasonal allergic rhinitis
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 28 Jan 2009 Status changed from active, no longer recruiting to completed, as reported on ClinicalTrials.gov.
- 20 Oct 2008 Last checked against ClinicalTrials.gov record.
- 07 Nov 2006 Status change